Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data

    PhaseV raises $50M to expand AI-powered clinical trial platform

    PhaseV has secured $50 million in Series A funding to [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    FTD trial milestone reached as Vesper Bio enrols first asymptomatic GRN carriers

    Vesper Bio has reached a key enrolment milestone in its [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    High hopes: Ajna turns psychedelics and cannabis into prescription science

    May 5, 2026
  • Clinical & Regulatory

    DFE Pharma secures ISO 22301 certification to safeguard excipients supply

    DFE Pharma has achieved ISO 22301 certification for Business Continuity [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Elsevier expands database with ClinicalTrials.gov to support drug and device development

    Elsevier has announced the addition of over 500,000 clinical trial [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Pharma giants eye obesity trial boom — but are they ready for what comes next?

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    New study urges EU to overhaul regulatory landscape to remain competitive in pharma innovation

    Research from Bayes Business School and Merck KGaA identifies barriers [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    PlaqueTec interim trial data shows promise for precision approach in coronary artery disease

    May 5, 2026
  • Clinical & Regulatory

    Emmes Group’s OptymEdge to launch first dedicated ophthalmology clinical trial platform at ARVO 2025

    May 5, 2026
  • Clinical & Regulatory

    Rein Therapeutics to integrate Qureight’s Deep-Learning Imaging Platform in Upcoming IPF Trial

    May 5, 2026
Previous757677Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Mission Therapeutics signs US$292M deal for acute kidney injury programme
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Research & Development
  • Medicus receives FDA feedback and IRB approval for Teverelix Phase 2 urinary retention trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top